Obstetrics & Gynecology Doctors in Hudson, WI Accepting Medicare

6 Obstetrics & Gynecology doctors found. Showing 1 - 6

Emily Linklater, DO Obstetrics & Gynecology - Obstetrics Medicare: Accepting Medicare Assignments Practice Location: 2651 Hillcrest Drive, Hudson, WI 54016 Phone: 715-531-6800    Fax: 715-531-6801

Alyssa J Lynch, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2651 Hillcrest Drive, Hudson, WI 54016 Phone: 715-531-6800    Fax: 715-531-6801

Dr. Morgan Leigh Barnum, D.O. Obstetrics & Gynecology - Obstetrics Medicare: Accepting Medicare Assignments Practice Location: 2651 Hillcrest Dr, Hudson, WI 54016 Phone: 715-531-6800    Fax: 715-531-6801

Dr. Brenton Curtis Jenkins, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 403 Stageline Rd, Hudson, WI 54016 Phone: 715-531-6800    Fax: 715-531-6801

Dr. Jonathan L Susa I, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2651 Hillcrest Drive, Hudson, WI 54016 Phone: 715-531-6800    Fax: 715-531-6801

Mrs. Karen L Ringgenberg, RN, MSN, WHNP Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 879 Highlander Trl, Hudson, WI 54016 Phone: 999-999-9999    Fax: 999-999-9999

News Archive

Australian anti-cancer company completes $2.6 million placement

Australian monoclonal antibody company, Immune System Therapeutics Limited (IST), today said it completed a private placement to raise $2 million from new and existing private and institutional investors in Australia. Investors have agreed to purchase 5,200,000 shares in the company at a price of $0.50 cents per share resulting in gross proceeds of $2.6 million.

Women who lack social ties have greater odds of being obese, UBC study says

Women who lack social ties have a greater likelihood of being obese, according to new UBC research published today in PLOS One. Men, on the other hand, were less likely to be obese if they lived alone and had a smaller social network.

UCSF researchers develop molecular 'on switch' that allows control over the actions of T cells

UC San Francisco researchers have engineered a molecular "on switch" that allows tight control over the actions of T cells, immune system cells that have shown great potential as therapies for cancer. The innovation lays the groundwork for sharply reducing severe, sometimes deadly side effects that have been a significant hurdle to advancing T cell-based treatments.

CDC recommends new vaccine for shingles

Last month a U.S. Food and Drug Administration (FDA) advisory panel had voted 11 to 0 approving a shingles vaccine for its use in adults aged 50 and over. The panel unanimously accepted the safety and efficacy of the vaccine and thus GlaxoSmithKline's Shingrix.

State highlights: Blue Cross Blue Shield dominant in Texas

A selection of health policy stories from Texas, New Jersey, Connecticut, Georgia, Missouri and New Mexico.

Read more Medical News

› Verified 7 days ago